LUYE PHARMA

02186 HKG
5.970
0.000
0.00%
Closed 16:10 05/24 HKT
Open
5.970
Prev Close
5.970
High
6.100
Low
5.970
Volume
9.75M
Avg Vol (3M)
15.31M
52 Week High
9.860
52 Week Low
4.880
% Turnover
0.30%
Market Cap
19.55B
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Related

Webull offers LUYE PHARMA 02186 stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Luye Pharma Group Ltd. is an investment holding company principally engaged in the development, production, marketing and sale of pharmaceutical products. Along with subsidiaries, the Company operates its business through four segments: the Oncology Drugs segment, the Cardiovascular System Drugs segment, the Alimentary Tract and Metabolism Drugs segment and the Others segment. The Company’s main products include paclitaxe for chemotherapy treatment of cancer, sodium glycididazole for radiotherapy for solid tumours, Chinese medicine for treatment of hypercholesterolaemia, and Rivastigmine Transdermal Patches for treatment of Alzheimer’s disease and dementia, among others. The products are sold under the name of Lipusu, CMNa, Xuezhikang, Maitongna ,and Bei X. Through its subsidiaries, the Company is also engaged in the provision of contract research and process development. The Company operates its business mainly in Mainland China.
MORE >

Recently

Name
Price
%Change